Fluoxetine Capsules — Class II drug recall D-1279-2014
Terminated recall by Legacy Pharmaceutical Packaging, reported 2014-05-07, distributed nationwide. Chemical Contamination: The recalling firm received notice that their supplier is recalling capsules due to co
| Recall number | D-1279-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Legacy Pharmaceutical Packaging, Earth City, MO, United States |
| Recall initiated | 2014-02-14 |
| Classified | 2014-04-28 |
| Reported by FDA | 2014-05-07 |
| Terminated | 2017-11-27 |
| Distributed | Nationwide (US) |
| Quantity | 667,068 bottles |
| Reason classes | chemical contamination |
| UPC / GTIN / UDI-DI | 00368645130545 |
| NDC | 68645-0130, 68645-0130-54, 68645-0131, 68645-0131-54 |
| Lot numbers | 08/15, 09/15, 11/15, 131328, 131634, 131833 |
Product
Fluoxetine Capsules, USP, 20 mg, 30-count bottles, Rx only, Distributed by: Wal-Mart, Bentonville, AR 72716; Manufactured by: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960; Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045, NDC 68645-130-54, UPC 3 68645 13054 5.
Reason for recall
Chemical Contamination: The recalling firm received notice that their supplier is recalling capsules due to complaints of capsules having an unusual odor.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1279-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.